{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:24:43Z","timestamp":1789907083722,"version":"4.0.1"},"reference-count":55,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2008,7,10]],"date-time":"2008-07-10T00:00:00Z","timestamp":1215648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Alcoholism Clin &amp;amp; Exp Res"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:p>\n                    <jats:bold>Background:\u2002<\/jats:bold>\n                    Selective breeding of rats over generations and induction of alcohol dependence via chronic vapor inhalation both enhance alcohol consumption in animal models. The purpose of this study was to determine whether dependence\u2010induced increases in alcohol consumption by P rats is sensitive to naltrexone, a general opioid receptor antagonist (but with highest affinity at the \u03bc\u2010opioid receptor at low doses), and the recently characterized small molecule CRF\n                    <jats:sub>1<\/jats:sub>\n                    \u2010receptor antagonist MPZP (\n                    <jats:italic>N,N<\/jats:italic>\n                    \u2010bis(2\u2010methoxyethyl)\u20103\u2010(4\u2010methoxy\u20102\u2010methylphenyl)\u20102,5\u2010dimethyl\u2010pyrazolo[1,5\u2010\n                    <jats:italic>a<\/jats:italic>\n                    ]pyrimidin\u20107\u2010amine).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:\u2002<\/jats:bold>\n                    P rats (\n                    <jats:italic>n\u2003<\/jats:italic>\n                    =\n                    <jats:italic>\u2003<\/jats:italic>\n                    20) were trained to respond for alcohol and water in a 2\u2010lever operant situation during daily 30\u2010minute sessions. P rats were then matched for alcohol intake and exposed to chronic intermittent alcohol vapor (\n                    <jats:italic>n\u2003<\/jats:italic>\n                    =\n                    <jats:italic>\u2003<\/jats:italic>\n                    10) or ambient air (\n                    <jats:italic>n\u2003<\/jats:italic>\n                    =\n                    <jats:italic>\u2003<\/jats:italic>\n                    10) for approximately 10\u2003weeks. All rats were then administered MPZP and naltrexone in 2 separate and consecutive Latin\u2010square designs.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:\u2002<\/jats:bold>\n                    MPZP attenuated dependence\u2010induced increases in alcohol intake by P rats while having no effect on alcohol consumption by nondependent controls. Conversely, operant alcohol responding was reduced similarly in dependent and nondependent P rats by naltrexone.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:\u2002<\/jats:bold>\n                    These results confirm a role for brain CRF\n                    <jats:sub>1<\/jats:sub>\n                    \u2010receptor systems in dependence\u2010induced changes in the reinforcing properties of alcohol, and CRF\n                    <jats:sub>1<\/jats:sub>\n                    \u2010receptor blockade appears to suppress dependence\u2010induced drinking at lower doses in P rats relative to other rat lines. Therefore, brain CRF\n                    <jats:sub>1<\/jats:sub>\n                    \u2010receptor systems are important in the regulation of dependence\u2010induced alcohol consumption, whereas brain opioid systems are important in the regulation of basal alcohol consumption by rats.\n                  <\/jats:p>","DOI":"10.1111\/j.1530-0277.2008.00745.x","type":"journal-article","created":{"date-parts":[[2008,7,9]],"date-time":"2008-07-09T13:53:14Z","timestamp":1215611594000},"page":"1535-1542","source":"Crossref","is-referenced-by-count":96,"title":["Effects of CRF\n                    <sub>1<\/sub>\n                    \u2010Receptor and Opioid\u2010Receptor Antagonists on Dependence\u2010Induced Increases in Alcohol Drinking by Alcohol\u2010Preferring (P) Rats"],"prefix":"10.1111","volume":"32","author":[{"given":"Nicholas W.","family":"Gilpin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather N.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George F.","family":"Koob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,8,25]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(86)90325-5"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(80)90257-X"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02244208"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1990.tb01234.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300282"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2007.03.009"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0031-9384(94)00382-F"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245418"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1999.tb04350.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1994.tb19817.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3096-06.2006"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.03.063"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0741-8329(94)90083-3"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(87)90021-9"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4985-06.2007"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568026043451573"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2008.00678.x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0604419103"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2007.06.006"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(97)00130-9"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1997.tb03840.x"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130051069"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2004.08.042"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2000.tb04608.x"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000057122.36127.C2"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(97)00474-7"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0741-8329(91)90417-U"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(79)90040-1"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-691403-0.50056-2"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(86)90079-1"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-8329(98)00021-4"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.15-08-05439.1995"},{"key":"e_1_2_6_34_1","first-page":"334","article-title":"Kappa\u2010opioid receptor\u2010mediated antinociception in the rat. I. Comparative actions of mu\u2010 and kappaopioids against noxious thermal, pressure and electrical stimuli","volume":"251","author":"Millan MJ","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_35_1","first-page":"342","article-title":"Kappa opioid receptor\u2010mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action","volume":"251","author":"Millan MJ","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0741-8329(89)90037-2"},{"key":"e_1_2_6_37_1","volume-title":"Guide for the Care and Use of Laboratory Animals","author":"National Research Council","year":"1996"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000145781.11923.4E"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2003.11.010"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2005.03.006"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2007.00445.x"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2007.10.008"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2000.tb01979.x"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2004.08.018"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0546-5"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.01.010"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/0741-8329(93)90046-Q"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-8329(97)00131-6"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2004.09.020"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1992.01820110040006"},{"key":"e_1_2_6_51_1","article-title":"Pharmacological evidence for a motivational role of kappa\u2010opioid systems in ethanol dependence","author":"Walker BM","year":"2007","journal-title":"Neuropsychopharmacol"},{"key":"e_1_2_6_52_1","first-page":"959","article-title":"In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats","volume":"271","author":"Walker EA","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(82)90459-2"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2006.00272.x"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2008.01.007"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-012373947-6.00412-8"}],"container-title":["Alcoholism: Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1530-0277.2008.00745.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1530-0277.2008.00745.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T20:43:04Z","timestamp":1697143384000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1530-0277.2008.00745.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,25]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1111\/j.1530-0277.2008.00745.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1530-0277.2008.00745.x","archive":["Portico"],"relation":{},"ISSN":["0145-6008","1530-0277"],"issn-type":[{"value":"0145-6008","type":"print"},{"value":"1530-0277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,25]]}}}